← FDA DRUG APPROVALS

FDA NDA · NDA019561

MICRO-K LS

Sponsor: KV PHARM

APPLICATION
NDA019561
TYPE
NDA
ORIGINAL APPROVAL
1988-08-26
LATEST ACTION
2005-08-22
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

MICRO-K LS · ReferenceDiscontinued
POTASSIUM CHLORIDE 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · FOR SUSPENSION, EXTENDED RELEASE · ORAL

Approval history

2005-08-22Labeling · Supplement 4 · standard — Letter ↗AP
1998-01-13Manufacturing (CMC) · Supplement 1 · standardAP
1988-08-26Type 3 - New Dosage Form · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →